Actos - Recall

However, the drug has faced bans in other countries and intense legal scrutiny due to serious health concerns. Key Safety Warnings and Bans

: In June 2011, the FDA issued a safety communication warning that using Actos for more than one year may increase the risk of bladder cancer by 40%. ACTOS RECALL

Takeda Pharmaceuticals , the manufacturer, has faced thousands of lawsuits from patients alleging they were not properly warned about the risk of bladder cancer. Actos Recall in the U.S. | Girard Gibbs LLP However, the drug has faced bans in other

While there have been significant legal and international developments, it is important to clarify that . ACTOS RECALL